Evaluation of pregnancy outcomes after thyroid surgery

Abstract

Background: According to contemporary cancer data, women account for roughly 75% of differentiated thyroid carcinoma (DTC), with the largest incidence occurring in individuals aged 50-59 years in the United States. Objective: This paper aims to evaluate of pregnancy outcomes after thyroid surgery. Patients and methods: This paper was interested to analyse and evaluate of pregnancy outcomes after thyroid surgery by radioactive iodine therapy, which includes 42 cases of pregnant women which suffered of thyroid and processes of thyroid surgery were applied in different hospitals in Iraq from 15th March 2021 to 27th July 2022. This data collected were analysed and conducted all demographic characteristics by the SPSS program. Discussion: This paper was presented different outcomes of pregnant women patients where it presented that the women have overweight were more struggled than those underweight due to a goiter which causes an overweight. In addition, the outcomes of pregnancy outcomes after surgery were got low birth weight; baby were most of the risk factors that have a high influenced on the women after pregnancy, with where it covered 7.1% of women. Furthermore, in the evaluations of blood pressure measurements post-operative of pregnant women surgery where this study diastolic blood pressure of women measurements after surgery and during surgery which found 57.14% for women have a blood pressure of <80 mm Hg and 23.81 for women have 80-89 mm Hg as well as 19.05 for women have >90 mm Hg. Conclusion: In conclusion, this study indicates that there is uncontrolled hyperthyroidism in pregnant patients, which causes many effects. In addition, this study showed that thyroidectomy surgery was successful, but our study found that there is an increased risk in the case of premature delivery before radioactive iodine treatment. After thyroid surgery, radioactive iodine therapy may be required in some thyroid cancer instances. As of currently, this paper suggests women waiting at least six months before getting pregnant after receiving radioactive iodine therapy due to worries about potential radiation impacts on the unborn child's development.